These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20870699)

  • 21. Goodbye avandia!
    Alzaid AA
    Saudi Med J; 2010 Dec; 31(12):1301-2. PubMed ID: 21135990
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical consequences of disseminating the rosiglitazone FDA safety warning.
    Orrico KB; Lin JK; Wei A; Yue H
    Am J Manag Care; 2010 May; 16(5):e111-6. PubMed ID: 20455636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. After Avandia, some seek split in drug approval and monitoring.
    Dolgin E
    Nat Med; 2010 Aug; 16(8):831. PubMed ID: 20689527
    [No Abstract]   [Full Text] [Related]  

  • 24. FDA advisers favor easing rosiglitazone restrictions.
    Traynor K
    Am J Health Syst Pharm; 2013 Jul; 70(14):1184-5. PubMed ID: 23820451
    [No Abstract]   [Full Text] [Related]  

  • 25. Playing the numbers game.
    Drug Ther Bull; 2011 Jan; 49(1):1. PubMed ID: 21220251
    [No Abstract]   [Full Text] [Related]  

  • 26. The truth about rosiglitazone (avandia).
    Ledbetter C; Laustsen G
    Nurse Pract; 2008 Jun; 33(6):10-1. PubMed ID: 18528195
    [No Abstract]   [Full Text] [Related]  

  • 27. Diabetes recall. Though Rezulin's withdrawal is a blow for some patients, there are ways to cope. Here's how.
    Gorman C
    Time; 2000 Apr; 155(13):94. PubMed ID: 11009709
    [No Abstract]   [Full Text] [Related]  

  • 28. Lessons from the Avandia controversy: a new paradigm for the development of drugs to treat type 2 diabetes.
    Misbin RI
    Diabetes Care; 2007 Dec; 30(12):3141-4. PubMed ID: 18042753
    [No Abstract]   [Full Text] [Related]  

  • 29. FDA warning and removal of rosiglitazone from VA national formulary.
    Aspinall SE; Zhao X; Good CB; Stone RA; Smith KJ; Cunningham FE
    Am J Manag Care; 2013 Sep; 19(9):748-58. PubMed ID: 24304257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value equation for rosiglitazone and pioglitazone in older persons.
    Zarowitz BJ
    Geriatr Nurs; 2008; 29(1):9-11. PubMed ID: 18267172
    [No Abstract]   [Full Text] [Related]  

  • 31. Significant FDA approvals in 1999.
    McGinnis TJ
    Am Fam Physician; 2000 Apr; 61(8):2531-3. PubMed ID: 10794586
    [No Abstract]   [Full Text] [Related]  

  • 32. Revisiting the rosiglitazone story--lessons learned.
    Rosen CJ
    N Engl J Med; 2010 Aug; 363(9):803-6. PubMed ID: 20660395
    [No Abstract]   [Full Text] [Related]  

  • 33. Rosiglitazone, marketing, and medical science.
    Moynihan R
    BMJ; 2010 Apr; 340():c1848. PubMed ID: 20375091
    [No Abstract]   [Full Text] [Related]  

  • 34. FDA Modernization Act: implications for oncology.
    Morris L
    Oncology (Williston Park); 1998 Nov; 12(11A):139-41. PubMed ID: 10028506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug safety. Planned study of Avandia in doubt after FDA review.
    Kean S
    Science; 2010 Jul; 329(5990):375. PubMed ID: 20651123
    [No Abstract]   [Full Text] [Related]  

  • 37. FDA evaluates accelerated approval process. Food and Drug Administration.
    Common Factor; 1995 Apr; (no 10):18. PubMed ID: 11362343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDA places "black box" warning on antidiabetes drugs.
    Tanne JH
    BMJ; 2007 Jun; 334(7606):1237. PubMed ID: 17569906
    [No Abstract]   [Full Text] [Related]  

  • 39. Suggested FDA restrictions might curtail access to mifepristone.
    Contracept Technol Update; 2000 Aug; 21(8):89-91. PubMed ID: 12349758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDA new drug approvals in 2010.
    Wynn RL
    Gen Dent; 2011; 59(4):250-3. PubMed ID: 21903562
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.